Vinge advises Bridgepoint in its agreement to acquire a significant controlling stake in Safe Life, a global leader in the distribution of automated external defibrillators (AEDs), in a transaction that values the company at c. €500 million.

Headquartered in Stockholm, Safe Life operates across North America and Europe and is a market leader in a highly fragmented and fast-growing sector. The company equips communities and workplaces with lifesaving AEDs supported by ongoing services, including CPR training, maintenance and replacement parts such as pads and batteries to enable a fast and effective response in an emergency.

Bridgepoint will partner with Safe Life’s founders and existing institutional investors including Byggmästaren, Bonnier Capital and Swedbank Robur, all of whom are materially reinvesting alongside Bridgepoint.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted mainly of Daniel Rosvall, Samra Tesser, Johanna Hamrefält, Sara Hammond and Oliwer Vidarsson (M&A), Albert Wållgren, Josefine Lanker, Calle Tengwall Pagels and Gabriel Chabo (Banking and Finance), Mario Saad, Filippa Eriksson and Carla Håkansson (Commercial Agreements, IT and GDPR), Christoffer Nordin (Regulatory Permits), Simon Söderholm and Viktor Lundberg (Employment), Ian Jonson (IP), Hanna Kövamees and Wilma Hellman (Real Estate and Environment), Sebastian Örndahl, Fredrik Hellström and Hilda Ivarsson (FDI), Julia Ulander Kull (Transaction Support Coordinator).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025